Thermal, spectroscopic, and dissolution studies of the simvastatin- acetylsalicylic acid mixtures

Journal of Thermal Analysis and Calorimetry

Volumn 111, Issue 3, 2013, Pages 2125-2132

  Górniak, Agata ^a   Karolewicz, Bozena ^a   Zurawska Płaksej, Ewa ^a   Pluta, Janusz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Aspirin; Dissolution enhancement; Eutectic; Phase diagram; Simvastatin; Solid dispersion

Indexed keywords

ACETYL SALICYLIC ACID; ACETYLSALICYLIC ACIDS; ASPIRIN; MECHANICAL ACTIVATION; SIMVASTATIN; SODIUM LAURYL SULFATES; SOLID DISPERSION; X-RAY POWDER DIFFRACTOMETRY;

DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; GRINDING (MACHINING); INFRARED SPECTROSCOPY; MICROCRYSTALS; MIXTURES; PHASE DIAGRAMS;

EUTECTICS;

EID: 84881478244     PISSN: 13886150     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10973-012-2641-7     Document Type: Article

References (42)

1. Seedher N, Sharma P. Solubility and stability enhancement of poorly-soluble drugs clarithromycin and prednisolone by combination with other drugs. Int J Biol Chem. 2007;1:229-36.
2. Mihos CG, Salas MJ, Santana O. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review. Cardiol Rev. 2010;18:298-304.
3. Tandon V, Bano G, Khajuria V, Parihar A, Gupta S. Pleiotropic effects of statins. Indian J Pharmacol. 2005;37:77-85.
4. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109:III39-40.
5. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89-118.
6. Schneider MP, Bernhard M, Schmidt BM, John S, Schmieder RE. Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels. J Hypertens. 2011;29:1757-64.
7. Awtry E, Loscazlo J. Aspirin. Circulation. 2000;101:1206-18.
8. Van Gijn J, Algra A. Aspirin and stroke prevention. Thromb Res. 2003;110:349-53.
9. Tirnaksiz E, Pamukcu B, Oflaz H, Nisanci Y. Effect of high dose statin therapy on platelet function; statins reduce aspirin resistant platelet aggregation in patients with coronary heart disease. J Thromb Thrombolysis. 2009;27:24-8.
10. Hennekens CH, Sacks FM, Tonkin A, Jukema JW, Byington RP, Pitt B, Berry DA, Berry SM, Ford NF, Walker AJ, Natarajan K, Sheng-Lin C, Fiedorek FT, Belder R. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses. Arch Intern Med. 2004;164:40-4.
11. Fisher M, Cushman M, Knappertz V, Howard G. An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration. Am Heart J. 2008;156:106-11.
12. Hassan HM, El-Gayar AM, Ibrahim TM, Al-Gayyar MMH. Anti-inflammatory effect of simvastatin-aspirin combination. Int J Pharm Sci Drug Res. 2011;3:89-96.
13. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413-20.
14. Joshi HN, Fakes MG, Serajuddin ATM. Differentiation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors by their relative lipophilicity. Pharm Pharmacol Commun. 1999;5:269-71.
15. Ellison DK, Moore WD, Petts CR. Simvastatin. In: Brittain HG, editor. Analytical profiles of drug substances and excipients. San Diego: Academic Press Inc.; 1993. p. 359-88.
16. Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharm. 2004;19:117-25.
17. Varshosaz J, Tavakoli N, Salamat FA. Enhanced dissolution rate of simvastatin using spherical crystallization technique. Pharm Dev Technol. 2011;16:529-35.
18. Silva TD, Arantes VT, Resende JALC, Speziali NL, de Oliveira RB, Vianna-Soares CD. Preparation and characterization of solid dispersion of simvastatin. Drug Dev Ind Pharm. 2010;36:1348-55.
19. Mandal D, Ojha PK, Nandy BC, Ghosh LK. Effect of carriers on solid dispersions of simvastatin (Sim): physico-chemical characterizations and dissolution studies. Der Pharm Lett. 2010;2:47-56.
20. Patel R, Patel M. Preparation, characterization, and dissolution behavior of a solid dispersion of simvastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. J Disper Sci Technol. 2008;2:193-204.
21. Rao M, Mandage Y, Khole I, Munjapara G. Characterization of solid dispersions of simvastatin with PVP K30 and poloxamer 188. Ind J Pharm Educ Res. 2011;45:145-52.
22. Süle A, Csempesz F. Complexation of statins with β-cyclodextrin in solutions of small molecular additives and macromolecular colloids. Progr Colloid Polym Sci. 2008;135:93-100.
23. Jun SW, Kim M-S, Kim J-S, Park HJ, Lee S, Woo J-S, Hwang S-J. Preparation and characterization of simvastatin/hydroxypropyl-β-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm. 2007;66:413-21.
24. Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007;12:1068-75.
25. Verma S, Rawat A, Kaul M, Saini S. Solid dispersion: a strategy for solubility enhancement. Int J Pharm Technol. 2011;3:1062-99.
26. Yuan X, Capomacchia AC. The binary eutectic of NSAIDs and two-phase liquid system for enhanced membrane permeation. Pharm Dev Technol. 2005;1:1-10.
27. Yuan X, Capomacchia AC. Physicochemical studies of binary eutectic of ibuprofen and ketoprofen for enhanced transdermal drug delivery. Drug Dev Ind Pharm. 2010;36:1168-76.
28. Lin D, Huang Y. A thermal analysis method to predict the complete phase diagram of drug-polymer solid dispersions. Int J Pharm. 2010;399:109-15.
29. Szterner P, Legendre B, Sghaier M. Thermodynamic properties of polymorphic forms of theophylline, Part I: DSC, TG, X-ray study. J Therm Anal Calorim. 2010;99:325-35.
30. Gilchrist SE, Letchford K, Burt HM. The solid-state characterization of fusidic acid. Int J Pharm. 2012;422:245-53.
31. Aignera Z, Berkesib O, Farkasa G, Szabó-Révésza P. DSC, X-ray and FTIR studies of a gemfibrozil/dimethyl-β-cyclodextrin inclusion complex produced by co-grinding. J Pharm Biomed Anal. 2012;57:62-7.
32. Basu P, Alexander KS, Riga A. A statistical model for the optimization of DSC performance in the evaluation of drugs for preformulation studies. J Therm Anal Calorim. 2006;83:19-22.
33. Oliveira PR, Bernardi LS, Murakami FS, Mendes C, Silva MAS. Thermal characterization and compatibility studies of norfloxacin for development of extended release tablets. J Therm Anal Calorim. 2009;97:741-5.
34. Höhne GWH, Hemmninger W, Flammersheim H-J. Differential scanning calorimetry. Berlin: Springer; 1996.
35. Gabott P. Principles and applications of thermal analysis. Oxford: Blackwell Publishing; 2008.
36. Polish Pharmacopoeia VIII. Warsaw: Ministry of Health; 2008.
37. Al-Suwayeh SA, Ahmed MO, Mahrous GM, Taha EI. Preparation and in vitro evaluation of tablets containing triple drug combination used for prevention/treatment of cardiovascular diseases. Aust J Basic Appl Sci. 2009;3:3684-91.
38. El-Banna HM. Solid dispersion of pharmaceutical ternary systems I: phase diagram of aspirin-acetaminophen-urea system. J Pharm Sci. 1978;67:1109-11.
39. Law SL, Lo WY, Lin FM, Chiang CH. Compatibility study of propoxyphene HCl solid mixtures using differential scanning calorimetry. Drug Dev Ind Pharm. 1988;14:1465-70.
40. Sangster J. Phase diagrams and thermodynamic properties of binary systems of drugs. J Phys Chem Ref Data. 1999;28:889-930.
41. Campanella L, Micieli V, Tomassetti M, Vecchio S. Solid-liquid phase diagrams of binary mixtures. Acetylsalicylic acid(1) + E(2) (E 5 salicylic acid, polyethylene glycol 4000, d-mannitol). J Therm Anal Calorim. 2010;99:887-92.
42. Górniak A, Wojakowska A, Karolewicz B, Pluta J. Phase diagram and dissolution studies of the fenofibrate-acetylsalicylic acid system. J Therm Anal Calorim. 2011;104:1195-200.